- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06856512
Intradialytic Exercise and Remote Ischaemic Preconditioning: a Cardioprotective Role ? (EXPI-DIAL)
The aim of this clinical trial is to evaluate whether intermittent exercise and remote ischaemic preconditioning (rIPC) during haemodialysis (HD) can provide cardioprotection in adult patients (aged 20-79 years) undergoing HD for at least 3 months. The main questions to be answered are
Does intermittent exercise or rIPC reduce myocardial stunning during HD? Do these interventions have a beneficial effect on haemorheology, arrhythmias, systemic inflammation and HD efficiency? The investigators will compare three HD sessions: no intervention (HD-CONT), with moderate-intensity intermittent exercise (HD-EX), and with rIPC using cuff inflation (HD-rIPC) to see if HD6EX and HD-rIPC approaches offer enhanced cardioprotection.
Participants will:
Undergo three randomised HD sessions. Participate in 5 blocks of moderate-intensity exercise or rIPC during the HD sessions.
Have cardiac function and biomarkers assessed before, during and after HD.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Montpellier, France
- Aider Sante
-
Nîmes, France
- Aider Sante
-
Strasbourg, France
- CHU Strasbourg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients aged between 20 and 79 years.
- Patients on hemodialysis for more than 3 months.
- No engagement in regular exercise outside of dialysis.
- No prior exposure to intradialytic exercise within the past six months.
- No medical contraindications to physical activity.
- Life expectancy greater than 6 months.
- Patients with relative good echogenicity
Exclusion Criteria
- Patient is participating in another Category I interventional study, or has participated in another interventional study within the past 3 months
- The patient is in an exclusion period determined by a previous study
- The patient is under legal protection or under guardianship or curatorship It turns out to be impossible to give the patient informed information, or the patient refuses to sign the consent
- Pregnant, parturient or breastfeeding patient
- Patients with unstable coronary artery disease.
- Patients with peripheral artery disease (stage III or IV) in the lower limbs.
- Patients with limb amputation.
- Patients with musculoskeletal disorders impairing exercise.
- Presence of a pacemaker, cardiac stimulation device, or implantable cardioverter defibrillator (ICD).
- History of heart transplant.
- Patients with uncontrolled hypertension.
- Refractory anemia.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients issued from dialysis units (clinic)
Randomised, controlled, crossover, bicentric, single-blind, prospective, open-label, superiority clinical trial comparing 3 dialysis modalities: Procedure A: Standard dialysis Procedure B: Dialysis with intradialytic intermittent physical exercise Procedure C: Dialysis with intradialytic ischaemia/reperfusion sequence of the upper limb Each subject will realize the 3 sessions in a random order. |
The dialysis protocol integrates a sequence of five ischaemia/reperfusion blocks applied to the upper limb.
Each block consists of a 5-minute period of cuff inflation at a supra-systolic pressure individualized to each patient-20 mmHg above the limb occlusion pressure-followed by a 25-minute period of cuff deflation.
This intervention begins 30 minutes after the start of dialysis and is referred to as hemodialysis remote ischaemic preconditioning (HD-rIPC).
The exercise protocol consists of five sequential bouts of physical activity, initiated 30 minutes after the start of dialysis.
Each bout comprises a 5-minute cycling exercise at moderate intensity, corresponding to a Borg Scale rating of 12-14, followed by a 25-minute passive recovery phase.
This structured intervention is referred to as hemodialysis exercise (HD-EX).
The hemodialysis control condition (HD-CONT) consists of standard hemodialysis treatment without the integration of any additional interventions, such as exercise or ischaemia/reperfusion protocols.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in regional myocardial stunning.
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will use echocardiography to assess the number of left ventricular myocardial segments (using a 18-segment model), that demonstrate a reduction in longitudinal deformation greater than 20% at peak stress during hemodialysis, relative to baseline measurements obtained at the start of the dialysis session.
Their aim is to compare changes in regional wall motion abnormalities across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemorheology - blood viscosity
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in whole blood viscosity, measured using a cone-plate viscometer, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes in whole blood viscosity across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of dialysis and just before its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Hemorheology - erythrocyte deformability
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in erythrocyte deformability, measured using an ektacytometer, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of dialysis and just before its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Hemorheology - erythrocyte aggregation
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in erythrocyte aggregation, measured using an ektacytometer, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of dialysis and just before its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - fibrinogen
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in fibrinogen, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of dialysis and just before its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - miRNA
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in levels of circulating mi-RNAs, quantified by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Intraventricular pressure gradient
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in the left intraventricular pressure gradient, measured by postprocessing color Doppler M-mode echocardiographic images, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Hemodynamic parameters - cardiac output
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will measure cardiac output every 30minutes from the beginning to the end of dialysis during the 3 conditions.
Their aim is to compare the changes during HD across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
For HD-EX and HD-RIPC, the investigators will add a measure immediately after the interventions (exercise or vascular occlusion) to control for the effect of the intervention.
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Hemodynamic parameters - blood pressure
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will measure blood pressure every 30minutes from the beginning to the end of dialysis during the 3 conditions.
Their aim is to compare the changes during HD across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
For HD-EX and HD-RIPC, the investigators will add a measure immediately after the interventions (exercise or vascular occlusion) to control for the effect of the intervention.
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Intraventricular flow
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in the velocity vector fields of blood flow in the LV, calculated by postprocessing color Doppler echocardiographic images, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Sublingual microvasculature - proportion of perfused vessels
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess the variation in the proportion of perfused vessels, measured using a videomicroscope, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Sublingual microvasculature - functional capillary density
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess the variation in functional capillary density, measured using a videomicroscope, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Sublingual microvasculature - De Baker's score
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess the variation in De Baker's score, measured using a videomicroscope, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Sublingual microvasculature - per-capillary microcirculatory flow index
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess the variation in per-capillary microcirculatory flow index, measured using a videomicroscope, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Sublingual microvasculature - red blood cell mean velocity
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess the variation in red blood cell mean velocity, measured using a videomicroscope, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Sublingual microvasculature - total vessel density
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess the variation in total vessel density, measured using a videomicroscope, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
standard echocardiography - LA morphology and function
Time Frame: From enrollment
|
The investigators will evaluate the left atrial (LA) volumes during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the LA morphology and function of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - LV volumes
Time Frame: From enrollment
|
The investigators will evaluate the left ventricular (LV) volumes using echocardiography during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - LV global diastolic function - E wave
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will evaluate the variation in E wave by pulsed Doppler ehocardiography from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
standard echocardiography - LV global diastolic function - tricuspid regurgitation
Time Frame: From enrollment
|
The investigators will evaluate the tricuspid regurgitation by continuous-wave Doppler ehocardiography during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
It will be used to characterize left ventricular global diastolic function.
Measurements will be conducted 30 minutes before the onset of dialysis
|
From enrollment
|
|
standard echocardiography - RV systolic function - TAPSE
Time Frame: From enrollment
|
The investigators will evaluate the Tricuspid Annular Plane Systolic Excursion using echocardiography during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
It will be used to characterize right ventricular global systolic function.
Measurements will be conducted 30 minutes before the onset of dialysis
|
From enrollment
|
|
standard echocardiography - RV morphology - areas
Time Frame: From enrollment
|
The investigators will evaluate the right ventricular (RV) area at end-systole and end-diastole during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - RV global diastolic function - Et wave
Time Frame: From enrollment
|
The investigators will evaluate the Et wave by pulsed Doppler ehocardiography during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
It will be used to characterize right ventricular global diastolic function.
Measurements will be conducted 30 minutes before the onset of dialysis
|
From enrollment
|
|
Biological data - uraemic toxins - beta2-microglobulin
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in beta2-microglobulin level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - uraemic toxins - Indoxyl sulfate
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in indoxyl sulfate level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - uraemic toxins - p-Cresyl sulfate
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in p-Cresyl sulfate level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - uraemic toxins - myoglobin
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in myoglobin level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - uraemic toxins - free light chains
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in free light chains, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - cardiac biomarkers - NT-pro-BNP
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in NT-pro-BNP level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - cardiac biomarkers - BNP level
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in BNP level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - cardiac biomarkers - cardiac troponin T
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in cardiac troponin T level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - cardiac biomarkers - sST2
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in levels of soluble ST2, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
biological data - characterization of patients - sodium
Time Frame: From enrollment
|
The investigators will evaluate the blood level of sodium during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - potassium
Time Frame: From enrollment
|
The investigators will evaluate the serum level of potassium during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - calcium
Time Frame: From enrollment
|
The investigators will evaluate the serum level of calcium during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - phosphate
Time Frame: From enrollment
|
The investigators will evaluate the serum level of phosphate during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - vitamin D
Time Frame: From enrollment
|
The investigators will evaluate the serum level of vitamin D during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - parathyroid hormone
Time Frame: From enrollment
|
The investigators will evaluate the serum level of parathyroid hormone during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - creatinine
Time Frame: From enrollment
|
The investigators will evaluate the serum level of creatinine during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - creatinine clearance
Time Frame: From enrollment
|
The investigators will evaluate the creatinine clearance during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - urea
Time Frame: From enrollment
|
The investigators will evaluate the blood level of urea during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - Kt/V
Time Frame: From enrollment
|
The investigators will evaluate the Kt/V urea during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
|
From enrollment
|
|
biological data - characterization of patients - nPCR
Time Frame: From enrollment
|
The investigators will evaluate the normalized proteïn catabolic rate during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - albumin
Time Frame: From enrollment
|
The investigators will evaluate the serum level of albumin during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - characterization of patients - CRP
Time Frame: From enrollment
|
The investigators will evaluate the serum level of c-reactiv protein during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the progression of the disease in the patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - hematology - complete blood count
Time Frame: From enrollment
|
The investigators will evaluate the complete blood count during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the blood of patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - hematology - ferritin
Time Frame: From enrollment
|
The investigators will evaluate the serum ferritin level during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the blood of patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - hematology - transferrin saturation
Time Frame: From enrollment
|
The investigators will evaluate the transferrine saturation during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the blood of patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
Hematology - hematocrit
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in hematocrit, measured using an hemoglobinometer, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes in whole blood viscosity across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Hematology - hemoglobin
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in hemoglobin level, measured using an hemoglobinometer, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes in whole blood viscosity across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset and at the end of dialysis.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
biological data - lipidic profile - LDL cholesterol
Time Frame: From enrollment
|
The investigators will evaluate the LDL cholesterol during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the lipidic profile.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - lipidic profile - HDL cholesterol
Time Frame: From enrollment
|
The investigators will evaluate the HDL cholesterol during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the lipidic profile of patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - lipidic profile - triglycerides
Time Frame: From enrollment
|
The investigators will evaluate the triglycerides level during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrolment.
They will be used to characterize the lipidic profile of patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
Biological data - inflamation - ultra-sensitive c-reactive protein
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in ultra-sensitive c-reactive protein level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of the dialysis and at its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - inflamation - interleukin-6
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in interleukin-6 level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of the dialysis and at its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - inflamation - interleukin-10
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in interleukin-10 level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of the dialysis and at its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - inflamation - tumor necrosis factor-α
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in tumor necrosis factor-α level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of the dialysis and at its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - endothelial cell activation - intercellular adhesion molecule-1
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in intercellular adhesion molecule-1 level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of the dialysis and at its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - endothelial cell activation - vascular cell adhesion molecule-1
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in vascular cell adhesion molecule-1 level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of the dialysis and at its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - endothelial cell activation - endothelin
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in endothelin level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of the dialysis and at its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Biological data - endothelial cell activation - proendothelin
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in proendothelin level, measured by analysing blood sample, from the beginning to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A blood sample will be taken directly from the arterial line of the dialysis machine immediately at the onset of the dialysis and at its end.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
biological data - insulin resistance - glucose
Time Frame: From enrollment
|
The investigators will evaluate the glucose level during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to quantify the insulin resistance of patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - insulin resistance - glycated hemoglobin
Time Frame: From enrollment
|
The investigators will evaluate the glycated hemoglobin level during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to quantify the insulin resistance of patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
biological data - insulin resistance - insulin
Time Frame: From enrollment
|
The investigators will evaluate the insulin level during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to quantify the insulin resistance of patients.
A blood sample will be taken directly from the arterial line of the dialysis machine at the onset of dialysis.
|
From enrollment
|
|
Hemodynamic parameters - heart rate
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will measure heart rate every 30minutes from the beginning to the end of dialysis during the 3 conditions.
Their aim is to compare the changes during HD across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
For HD-EX and HD-RIPC, the investigators will add a measure immediately after the interventions (exercise or vascular occlusion) to control for the effect of the intervention.
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Hemodynamic parameters - stroke volume
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will measure stroke volume every 30minutes from the beginning to the end of dialysis during the 3 conditions.
Their aim is to compare the changes during HD across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
For HD-EX and HD-RIPC, the investigators will add a measure immediately after the interventions (exercise or vascular occlusion) to control for the effect of the intervention.
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Strains - LV
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in left longitudinal strains, using speckle tracking echocardiography, from before to the peak stress of dialysis. Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC). Strains (in %) measure the amount of myocardial longitudinal shortening of the cavity, are relatively load-independent, and can detect subclinical myocardial dysfunction, even when it is not apparent by conventional echocardiography. Patients will participate in all three conditions in a randomized order. A two-week period of standard dialysis will separate the execution of two consecutive sessions. |
From enrollment to the end of treatment at 7 weeks
|
|
Strains - RV
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in right ventricular longitudinal strains, using speckle tracking echocardiography, from before to the peak stress of dialysis. Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC). Strains (in %) measure the amount of myocardial longitudinal shortening of the cavity, are relatively load-independent, and can detect subclinical myocardial dysfunction, even when it is not apparent by conventional echocardiography. Patients will participate in all three conditions in a randomized order. A two-week period of standard dialysis will separate the execution of two consecutive sessions. |
From enrollment to the end of treatment at 7 weeks
|
|
Strains - LA
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in left atrial longitudinal strains, using speckle tracking echocardiography, from before to the peak stress of dialysis. Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC). Strains (in %) measure the amount of myocardial longitudinal shortening of the cavity, are relatively load-independent, and can detect subclinical myocardial dysfunction, even when it is not apparent by conventional echocardiography. Patients will participate in all three conditions in a randomized order. A two-week period of standard dialysis will separate the execution of two consecutive sessions. |
From enrollment to the end of treatment at 7 weeks
|
|
standard echocardiography - LV morphology - diameter
Time Frame: From enrollment
|
The investigators will evaluate the left ventricular (LV) diameter at both end-diastole and end-systole during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the LV morphology of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - LV morphology - wal thicknessess
Time Frame: From enrollment
|
The investigators will evaluate the left ventricular (LV) wall thicknesses at both end-diastole and end-systole during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the LV morphology of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - RV morphology - diameters
Time Frame: From enrollment
|
The investigators will evaluate the right ventricular (RV) diameters at end-systole and end-diastole during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the RV morphology of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - LV global systolic function
Time Frame: From enrollment
|
The investigators will evaluate the left ventricular (LV) ejection fraction using echocardiography during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to evaluate the LV global systolic function.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - LV morphology - mass
Time Frame: From enrollment
|
The investigators will evaluate the left ventricular (LV) mass during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the LV morphology of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
Myocardial work - global myocardial work
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in global myocardial work, using speckle tracking echocardiography and blood pressure, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
It provides a more precise assessment of cardiac performance than strains by considering the left ventricular loading condition.
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Myocardial work - global constructive work
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in global constructive work, using speckle tracking echocardiography and blood pressure, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
It provides a more precise assessment of cardiac performance than strains by considering the left ventricular loading condition.
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Myocardial work - global wasted work
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in global wasted work, using speckle tracking echocardiography and blood pressure, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
It provides a more precise assessment of cardiac performance than strains by considering the left ventricular loading condition.
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
Myocardial work - global work efficiency
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will assess variations in global work efficiency, using speckle tracking echocardiography and blood pressure, from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
It provides a more precise assessment of cardiac performance than strains by considering the left ventricular loading condition.
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
standard echocardiography - LV global diastolic function - A wave
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will evaluate the variation in A wave measured by pulsed Doppler ehocardiography from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
standard echocardiography - RV systolic function
Time Frame: From enrollment
|
The investigators will calculate the right ventricular fractional area change using echocardiography during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
It will be used to characterize right ventricular global systolic function.
Measurements will be conducted 30 minutes before the onset of dialysis
|
From enrollment
|
|
standard echocardiography - RV global diastolic function
Time Frame: From enrollment
|
The investigators will evaluate the At wave by pulsed Doppler ehocardiography during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
It will be used to characterize right ventricular global diastolic function.
Measurements will be conducted 30 minutes before the onset of dialysis
|
From enrollment
|
|
standard echocardiography - tissue Doppler imaging - LV e'
Time Frame: From enrollment
|
The investigators will evaluate the left ventricular (LV) e' wave by tissue Doppler imaging during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the LV regional function of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - tissue Doppler imaging - LV a'
Time Frame: From enrollment
|
The investigators will evaluate the left ventricular (LV) a' wave by tissue Doppler imaging during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the LV function of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - tissue Doppler imaging - LV s'
Time Frame: From enrollment
|
The investigators will evaluate the left ventricular (LV) s' waves by tissue Doppler imaging during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the LV regional function of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - tissue Doppler imaging - RV e'
Time Frame: From enrollment
|
The investigators will evaluate the right ventricular (RV) e' wave by tissue Doppler imaging during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the RV regional function of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - tissue Doppler imaging- RV a'
Time Frame: From enrollment
|
The investigators will evaluate the right ventricular (RV) a' wave by tissue Doppler imaging during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the RV regional function of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - tissue Doppler imaging - RV s'
Time Frame: From enrollment
|
The investigators will evaluate the right ventricular (RV) s' wave by tissue Doppler imaging during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the RV regional function of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - RV morphology and function - diameters
Time Frame: From enrollment
|
The investigators will evaluate the right ventricular (RV) outflow tract diameters during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the RV morphology and function of the patients.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - RV global diastolic function - Et/At ratio
Time Frame: From enrollment
|
The investigators will evaluate the Et/At ratio by pulsed Doppler ehocardiography during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
It will be used to characterize right ventricular global diastolic function.
Measurements will be conducted 30 minutes before the onset of dialysis
|
From enrollment
|
|
standard echocardiography - LV global diastolic function - E/A
Time Frame: From enrollment to the end of treatment at 7 weeks
|
The investigators will evaluate the E/A ratio by pulsed Doppler ehocardiography from before to the peak stress of dialysis.
Their aim is to compare these changes across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC).
Patients will participate in all three conditions in a randomized order.
A two-week period of standard dialysis will separate the execution of two consecutive sessions.
|
From enrollment to the end of treatment at 7 weeks
|
|
standard echocardiography - diastolic function - LV E/e'
Time Frame: From enrollment
|
The investigators will evaluate the left ventricular (LV) E/e' ratio during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the LV filling pressure.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
|
standard echocardiography - diastolic function - RV Et/e'
Time Frame: From enrollment
|
The investigators will evaluate the right ventricular (RV) Et/e' ratio during the first dialysis session (HD-CONT, HD-EX, or HD-rIPC, depending on the randomized order of the three sessions), after enrollment.
They will be used to characterize the RV filling pressure.
Measurements will be conducted 30 minutes before the onset of dialysis.
|
From enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laure Patrier, MD, PhD, AIDER Santé - Fondation Charles Mion
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AU-092024-CM
- LAPEC/2024/DIAL (Other Identifier: Avignon University)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemodialysis
-
National Taiwan University HospitalCompletedHemodialysis Complication | Hemodialysis-Induced SymptomTaiwan
-
University Hospital, GhentEnrolling by invitationPediatric | Efficiency | Hemodialysis Treatment | Hemodialysis PatientBelgium
-
Khon Kaen UniversityCompletedHemodialysis | Hemodialysis Treatment | Dialysis AdequacyThailand
-
Vantive Health LLCBaxter Healthcare Corporation; Gambro Renal Products, Inc.Completed
-
Osaka UniversityCompleted
-
Chinese PLA General HospitalWithdrawn
-
University of HyogoCompleted
-
DVX, LLCNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Renal...Completed
-
Dong-A UniversityCompletedHemodialysisKorea, Republic of
Clinical Trials on Remote ischaemic preconditioning
-
University of NottinghamCompletedVascular Diseases | HypertensionUnited Kingdom
-
Western University, CanadaAcademic Medical Organization of Southwestern OntarioTerminatedCardiovascular Diseases | Hemodialysis
-
University College London HospitalsCompletedCoronary Heart DiseaseUnited Kingdom
-
University College, LondonUniversity College London HospitalsUnknownCardiotoxicityUnited Kingdom
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingIschemic PreconditioningChina
-
Mid Western Regional Hospital, IrelandCompletedContrast Induced Nephropathy | Remote Ischaemic PreconditioningIreland
-
Sun Yat-sen UniversityGuangzhou First People's HospitalCompletedHeart Valve DiseasesChina
-
University College, LondonUniversity College London Hospitals; National Hospital for Neurology and Neurosurgery...Unknown
-
The University of Hong KongCompleted
-
NHS National Waiting Times Centre BoardUniversity of Glasgow; Chief Scientist Office of the Scottish Government; Chest...CompletedCoronary Disease | Ischemic PreconditioningUnited Kingdom